F-group (family)
304.48.1.1 RVT_1
Ligands and drugs
1,705
Member domains
749
with ligand contacts (≤ 4 Å)
43.9% of members
729
with DrugDomain annotations
42.8% of members
438
with a DrugBank compound
25.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 304.48.1.1 belongs to X-group 304 Alpha-beta plaits, which binds 8.8 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08864 | T27 | Rilpivirine | 62 |
| DB00238 | NVP | Nevirapine | 37 |
| DB00625 | EFZ | Efavirenz | 19 |
| DB02887 | D4T | Stavudine triphosphate | 16 |
| DB03222 | DTP | dATP | 16 |
| DB02181 | DGT | 2'-Deoxyguanosine-5'-Triphosphate | 10 |
| DB03258 | DCP | 2'-Deoxycytidine 5'-triphosphate | 10 |
| DB05871 | UC1 | UC-781 | 8 |
| DB06414 | 65B | Etravirine | 8 |
| DB07884 | HBQ | Opaviraline | 8 |
| DB07885 | HBY | Talviraline | 7 |
| DB08665 | U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE | 6 |
| DB02452 | TTP | Thymidine 5'-triphosphate | 5 |
| DB00145 | GLY | Glycine | 4 |
| DB02189 | DDS | 2',3'-Dideoxyadenosine triphosphate | 4 |
| DB02721 | PYZ | 4-Iodopyrazole | 4 |
| DB07332 | AAP | ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE | 4 |
| DB07797 | FTC | N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA | 4 |
| DB08600 | TBO | Tivirapine | 4 |
| DB08634 | TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 149 |
| T27 | 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile | 59 |
| NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE | 30 |
| DTP | 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE | 26 |
| Kmetal | POTASSIUM ION | 25 |
| D4T | 2',3'-DEHYDRO-2',3'-DEOXY-THYMIDINE 5'-TRIPHOSPHATE | 16 |
| CAmetal | CALCIUM ION | 14 |
| K5C | 4-({4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]piperidin-1-yl}methyl)benzene-1-sulfonamide | 14 |
| EFZ | (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE | 13 |
| CDmetal | CADMIUM ION | 12 |
| DCP | 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE | 12 |
| DGT | 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE | 12 |
| MNmetal | MANGANESE (II) ION | 11 |
| ET9 | [[(1R,3S,5S)-3-(2-azanyl-6-oxidanylidene-3H-purin-9-yl)-2-methylidene-5-oxidanyl-cyclopentyl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 8 |
| K5A | 4-[(4-{[4-(4-cyano-2,6-dimethylphenoxy)thieno[3,2-d]pyrimidin-2-yl]amino}piperidin-1-yl)methyl]benzene-1-sulfonamide | 8 |
| ZP4 | [[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl] [(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate | 8 |
| 65B | 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE | 7 |
| TTP | THYMIDINE-5'-TRIPHOSPHATE | 7 |
| 1RZ | Lamivudine Triphosphate | 6 |
| 9W3 | 4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino}-6-[3-(morpholin-4-yl)propoxy]-1,3,5-triazin-2-yl)amino]benzonitrile | 6 |